Sugi Predict

Sugi Predict / Compounds / SCHEMBL9604044

SCHEMBL9604044

SCHEMBL9604044

Cc1ccc(-c2cccc3nc(-c4ccc(-c5cccc6c5oc5ccccc56)cc4)oc23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.52
▸ RAB9A P51151 6/20 0.52
▸ ALOX5 P09917 2/20 0.48
▸ KDM4E B2RXH2 7/20 0.43
▸ ALDH1A1 P00352 6/20 0.43
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ HPGD P15428 5/20 0.43
▸ HSD17B10 Q99714 4/20 0.43
▸ TP53 P04637 3/20 0.43
▸ PTPN2 P17706 2/20 0.43
▸ PTPN1 P18031 2/20 0.43
▸ PTPN5 P54829 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ DHODH Q02127 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ SENP8 Q96LD8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9604034 0.91 ALOX5 (0.51) NPC1RAB9AALOX5KDM4EALDH1A1
SCHEMBL9604018 0.90 ALOX5 (0.48) NPC1RAB9AALOX5KDM4EALDH1A1
SCHEMBL9604035 0.90 DHODH (0.53) NPC1RAB9AALOX5KDM4EALDH1A1
SCHEMBL9604043 0.88 ALOX5 (0.45) NPC1RAB9AALOX5KDM4EALDH1A1
SCHEMBL9604038 0.88 ALOX5 (0.49) NPC1RAB9AALOX5KDM4EALDH1A1
SCHEMBL9604031 0.87 ALOX5 (0.48) NPC1RAB9AALOX5KDM4EALDH1A1
SCHEMBL9604032 0.87 ALOX5 (0.48) NPC1RAB9AALOX5KDM4EALDH1A1
SCHEMBL9603967 0.87 NPC1 (0.55) NPC1RAB9AALOX5KDM4EALDH1A1
SCHEMBL9604020 0.86 NPC1 (0.55) NPC1RAB9AALOX5KDM4EALDH1A1
SCHEMBL9604014 0.86 KDM4E (0.61) NPC1RAB9AALOX5KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 — — US disclosed
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 — — US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 — — US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device XDH, AOX1, CYP4X1 NPC1 4611/4885RAB9A 3002/4885ALOX5 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.